Cargando…
Anti-angiogenic therapies for advanced esophago-gastric cancer
Neo-vascularization is a vital process for tumor growth and development which involves the interaction between tumor cells and stromal endothelial cells through several growth factors and membranous receptors which ultimately activate pro-angiogenic intracellular signaling pathways. Inhibition of an...
Autores principales: | Fontana, Elisa, Sclafani, Francesco, Cunningham, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264270/ https://www.ncbi.nlm.nih.gov/pubmed/25538401 http://dx.doi.org/10.4103/0971-5851.144985 |
Ejemplares similares
-
Perspectives on the Management of Oligometastatic Disease in Esophago-Gastric Cancer
por: Goetze, Thorsten Oliver, et al.
Publicado: (2022) -
The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
por: Valkema, M. J., et al.
Publicado: (2022) -
Angiogenesis and Anti-Angiogenic Therapy in Gastric Cancer
por: Nienhüser, Henrik, et al.
Publicado: (2017) -
Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review
por: Tondolo, Vincenzo, et al.
Publicado: (2023) -
Recent Advances in Anti-Angiogenic Therapy of Cancer
por: Samant, Rajeev S., et al.
Publicado: (2011)